IntoCell Enters into Development and License Option Agreement with ADC Therapeutics
/PRNewswire/ -- IntoCell today announced the signing of a Material Transfer Agreement (MTA) with option to license with ADC Therapeutics SA (NYSE: ADCT). Under...
Source: prnewswire.com